Sarcopenia in chronic kidney disease on conservative therapy: Prevalence and association with mortality

Nephrology Dialysis Transplantation

Volumn 30, Issue 10, 2015, Pages 1718-1725

  Pereira, Raíssa A ^a   Cordeiro, Antonio C ^b   Avesani, Carla M ^c   Carrero, Juan J ^d   Lindholm, Bengt ^d   Amparo, Fernanda C ^b   Amodeo, Celso ^b   Cuppari, Lilian ^a   Kamimura, Maria A ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

^c STATE UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

chronic kidney disease; handgrip strength; mortality; muscle mass; sarcopenia

Indexed keywords

ADULT; AGED; ANALYZER; ARM CIRCUMFERENCE; ARM MUSCLE; ARTICLE; BODY FAT CALIPER; CHRONIC KIDNEY DISEASE; CONSERVATIVE TREATMENT; DISEASE ASSOCIATION; DYNAMOMETER; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; GRIP STRENGTH; HUMAN; IMPEDANCE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; MUSCLE ATROPHY; MUSCLE FUNCTION; MUSCLE MASS; PREDICTION; PREVALENCE; PRIORITY JOURNAL; SARCOPENIA; SKELETAL MUSCLE; YOUNG ADULT; ADOLESCENT; COMORBIDITY; COMPLICATION; HAND STRENGTH; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; SURVIVAL RATE; SWEDEN; VERY ELDERLY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; GLOMERULAR FILTRATION RATE; HAND STRENGTH; HUMANS; MALE; MIDDLE AGED; MUSCULAR ATROPHY; PREVALENCE; PROGNOSIS; RENAL INSUFFICIENCY, CHRONIC; SARCOPENIA; SURVIVAL RATE; SWEDEN; YOUNG ADULT;

EID: 84943369527     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfv133     Document Type: Article

References (43)

1. Morley JE, Abbatecola AM, Argiles JM, et al. Sarcopenia with limited mobility: an international consensus. J AmMed Dir Assoc 2011; 12: 403-409
2. Cruz-Jentoft AJ, Baeyens JP, Bauer JM, et al. Sarcopenia: European consensus on definition and diagnosis: report of the EuropeanWorking Group on sarcopenia in older people. Age Ageing 2010; 39: 412-423
3. Muscaritoli M, Anker SD, Argiles J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) cachexia-anorexia in chronic wasting diseases and nutrition in geriatrics. Clin Nutr 2010; 29: 154-159
4. Fielding RA, Vellas B, Evans WJ, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc 2011; 12: 249-256
5. Arango-Lopera VE, Arroyo P, Gutierrez-Robledo LM, et al. Mortality as an adverse outcome of sarcopenia. J Nutr Health Aging 2013; 17: 259-262
6. Axelsson J, Qureshi AR, Divino-Filho JC, et al. Are insulin-like growth factor and its binding proteins 1 and 3 clinically useful as markers of malnutrition, sarcopenia and inflammation in end-stage renal disease?. Eur J Clin Nutr 2006; 60: 718-726
7. Bauer JM, Sieber CC. Sarcopenia and frailty: a clinician's controversial point of view. Exp Gerontol 2008; 43: 674-678
8. Baumgartner RN, Koehler KM, Gallagher D, et al. Epidemiology of sarcopenia among the elderly in New Mexico. Am J Epidemiol 1998; 147: 755-763
9. Bijlsma AY, Meskers CG, Ling CH, et al. Defining sarcopenia: the impact of different diagnostic criteria on the prevalence of sarcopenia in a large middle aged cohort. Age (Dordr) 2013; 35: 871-881
10. Cederholm TE, Bauer JM, Boirie Y, et al. Toward a definition of sarcopenia. Clin Geriatr Med 2011; 27: 341-353
11. Cruz-Jentoft AJ, Landi F, Topinkova E, et al. Understanding sarcopenia as a geriatric syndrome. Curr Opin Clin Nutr Metab Care 2010; 13: 1-7
12. Ferrucci L, Russo CR, Lauretani F, et al. A role for sarcopenia in late-life osteoporosis. Aging Clin Exp Res 2002; 14: 1-4
13. Kim YS, Lee Y, Chung YS, et al. Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys. J Gerontol A Biol Sci Med Sci 2012; 67: 1107-1113
14. Fahal IH. Uraemic sarcopenia: aetiology and implications. Nephrol Dial Transplant 2014; 29: 1655-1665
15. Workeneh BT, Mitch WE. Review ofmuscle wasting associated with chronic kidney disease. Am J Clin Nutr 2010; 91: 1128S-1132S
16. Mijnarends DM, Meijers JM, Halfens RJ, et al. Validity and reliability of tools to measure muscle mass, strength, and physical performance in community-dwelling older people: a systematic review. J Am Med Dir Assoc 2013; 14: 170-178
17. Legrand D, Vaes B, Mathei C, et al. The prevalence of sarcopenia in very old individuals according to the European consensus definition: insights from the BELFRAIL study. Age Ageing 2013; 42: 727-734
18. Volpato S, Bianchi L, Cherubini A, et al. Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci 2013; 69: 438-446
19. Janssen I, Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatr Soc 2002; 50: 889-896
20. Noori N, Kopple JD, Kovesdy CP, et al. Mid-arm muscle circumference and quality of life and survival in maintenance hemodialysis patients. Clin J Am Soc Nephrol 2010; 5: 2258-2268
21. Araujo IC, Kamimura MA, Draibe SA, et al. Nutritional parameters and mortality in incident hemodialysis patients. J Ren Nutr 2006; 16: 27-35
22. Steiber A, Leon JB, Secker D, et al. Multicenter study of the validity and reliability of subjective global assessment in the hemodialysis population. J Ren Nutr 2007; 17: 336-342
23. Carrero JJ, Chmielewski M, Axelsson J, et al. Muscle atrophy, inflammation and clinical outcome in incident and prevalent dialysis patients. Clin Nutr 2008; 27: 557-564
24. Kim JK, Choi SR, Choi MJ, et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr 2014; 33: 64-68
25. Lamarca F, Carrero JJ, Rodrigues JC, et al. Prevalence of sarcopenia in elderly maintenance hemodialysis patients: the impact of different diagnostic criteria. J Nutr Health Aging 2014; 18: 710-717
26. Cordeiro AC, Qureshi AR, Lindholm B, et al. Visceral fat and coronary artery calcification in patients with chronic kidney disease. Nephrol Dial Transplant 2013; 28(Suppl 4): iv152-iv159
27. Cordeiro AC, Moraes AA, Cerutti V, et al. Clinical determinants and prognostic significance of the electrocardiographic strain pattern in chronic kidney disease patients. J Am Soc Hypertens 2014; 8: 312-320
28. Schlussel MM, dos Anjos LA, de Vasconcellos MTet al. Reference values of handgrip dynamometry of healthy adults: a population-based study. Clin Nutr 2008; 27: 601-607
29. Frisancho AR. New norms of upper limb fat and muscle areas for assessment of nutritional status. Am J Clin Nutr 1981; 34: 2540-2545
30. Fouque D, Kalantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int 2008; 73: 391-398
31. Adequacy of dialysis and nutrition in continuous peritoneal dialysis: association with clinical outcomes. Canada-USA (CANUSA) Peritoneal Dialysis Study Group. J Am Soc Nephrol 1996; 7: 198-207
32. Janssen I, Heymsfield SB, Baumgartner RN, et al. Estimation of skeletal muscle mass by bioelectrical impedance analysis. J Appl Physiol (1985) 2000; 89: 465-471
33. Janssen I, Baumgartner RN, Ross R, et al. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol 2004; 159: 413-421
34. Sargent JA, Gotch FA. Mass balance: a quantitative guide to clinical nutritional therapy. I. The predialysis patient with renal disease. J AmDiet Assoc 1979; 75: 547-551
35. Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-383
36. Patel HP, Syddall HE, Jameson K, et al. Prevalence of sarcopenia in community-dwelling older people in theUK using the EuropeanWorking Group on Sarcopenia in Older People (EWGSOP) definition: findings from the Hertfordshire Cohort Study (HCS) Age Ageing 2013; 42: 378-384
37. Cherin P, Voronska E, Fraoucene N, et al. Prevalence of sarcopenia among healthy ambulatory subjects: the sarcopenia begins from 45 years. Aging Clin Exp Res 2014; 26: 137-146
38. Gariballa S, Alessa A. Sarcopenia: prevalence and prognostic significance in hospitalized patients. Clin Nutr 2013; 32: 772-776
39. Cesari M, Penninx BW, PahorMet al. Inflammatory markers and physical performance in older persons: the InCHIANTI study. J Gerontol A Biol Sci Med Sci 2004; 59: 242-248
40. Kamimura MA, Avesani CM, Cendoroglo M, et al. Comparison of skinfold thicknesses and bioelectrical impedance analysis with dual-energy X-ray absorptiometry for the assessment of body fat in patients on long-term haemodialysis therapy. Nephrol Dial Transplant 2003; 18: 101-105
41. Kim JC, Kalantar-Zadeh K, Kopple JD. Frailty and protein-energy wasting in elderly patients with end stage kidney disease. J Am Soc Nephrol 2013; 24: 337-351
42. Bergman H, Ferrucci L, Guralnik J, et al. Frailty: an emerging research and clinical paradigm-issues and controversies. J Gerontol A Biol Sci Med Sci 2007; 62: 731-737
43. Morley JE, von Haehling S, Anker SD, et al. From sarcopenia to frailty: a road less traveled. J Cachexia Sarcopenia Muscle 2014; 5: 5-8